A proprietary transdermal delivery system utilizing sufentanil, a potent opioid, for the treatment of chronic pain.
View complete product pipeline
August 27, 2015DURECT to Participate in Upcoming Healthcare Conferences
August 03, 2015DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs
July 24, 2015DURECT Corporation Invites You to Join its Second Quarter 2015 Earnings Conference Call
June 29, 2015DURECT to Present at the Cantor Fitzgerald Healthcare Conference